The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
Open accessAbstract
The effect of various drugs on the extracellular concentration of dopamine in two terminal dopaminergic areas, the nucleus accumbens septi (a limbic area) and the dorsal caudate nucleus (a subcortical motor area), was studied in freely moving rats by using brain dialysis. Drugs abused by humans (e.g., opiates, ethanol, nicotine, amphetamine, and cocaine) increased extracellular dopamine concentrations in both areas, but especially in the accumbens, and elicited hypermotility at low doses. On the other hand, drugs with aversive properties (e.g., agonists of kappa opioid receptors, U-50,488, tifluadom, and bremazocine) reduced dopamine release in the accumbens and in the caudate and elicited hypomotility. Haloperidol, a neuroleptic drug, increased extracellular dopamine concentrations, but this effect was not preferential for the accumbens and was associated with hypomotility and sedation. Drugs not abused by humans [e.g., imipramine (an antidepressant), atropine (an antimuscarinic drug), and diphenhydramine (an antihistamine)] failed to modify synaptic dopamine concentrations. These results provide biochemical evidence for the hypothesis that stimulation of dopamine transmission in the limbic system might be a fundamental property of drugs that are abused.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Kelly, P. H., Seviour, P. W., & Iversen, S. D. (1975) · Brain Research · doi:10.1016/0006-8993(75)90233-4 · Cited by 1,740
Striatal Dopamine Release after Amphetamine or Nerve Degeneration Revealed by Rotational Behaviour
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb10999.x · Cited by 924
U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
VonVoigtlander, P. F., Lahti, R. A., & Ludens, J. H. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33422-1 · Cited by 814
Self-administration of psychoactive substances by the monkey
Deneau, G. A., Yanagita, T., & Seevers, M. H. (1969) · Psychopharmacology · doi:10.1007/bf00405254 · Cited by 808
Pettit, H. O., Ettenberg, A., Bloom, F. E., & Koob, G. F. (1984) · Psychopharmacology · doi:10.1007/bf00427441 · Cited by 651
Zetterström, T., Sharp, T., Marsden, C. A., & Ungerstedt, U. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00893.x · Cited by 616
Mucha, R. F., & Herz, A. (1985) · Psychopharmacology · doi:10.1007/bf00432213 · Cited by 515
Intracranial self-administration of morphine into the ventral tegmental area in rats
Bozarth, M. A., & Wise, R. A. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90148-x · Cited by 507
Impérato, A., & Chiara, G. D. (1984) · Journal of Neuroscience · doi:10.1523/jneurosci.04-04-00966.1984 · Cited by 456
Matthews, R. T., & German, D. C. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90048-4 · Cited by 426
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–261 of 261
Rezvani, A. H., Slade, S., Wells, C., Petro, A., Lumeng, L., Li, T.-K., Xiao, Y., Brown, M. L., Paige, M. A., McDowell, B. E., et al. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1878-8 · Cited by 88
Dawkins, L., Powell, J. H., West, R., Powell, J., & Pickering, A. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0634-6 · Cited by 85
Presynaptic plasticity: targeted control of inhibitory networks
McBain, C. J., & Kauer, J. A. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.05.008 · Cited by 79
Zachariou, V., Benoit-Marand, M., Allen, P. B., Ingrassia, P., Fienberg, A. A., Gonon, F., Greengard, P., & Picciotto, M. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01318-x · Cited by 84
Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens
Przewłocka, B., Turchan, J., Lasoń, W., & Przewłocki, R. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00829-x · Cited by 80
Petit, G., Kornreich, C., Verbanck, P., & Campanella, S. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.04.005 · Cited by 81
Nicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81
Feed-forward mechanisms: Addiction-like behavioral and molecular adaptations in overeating
Alsiö, J., Olszewski, P. K., Levine, A. S., & Schiöth, H. B. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.01.002 · Cited by 81
Leri, F., Tremblay, A., Sorge, R. E., & Stewart, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300435 · Cited by 80
Dopamine Circuit Mechanisms of Addiction-Like Behaviors
Poisson, C. L., Engel, L., & Saunders, B. T. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.752420 · Cited by 75
Drug addiction: from bench to bedside
Cheron, J., & Kerchove d’Exaerde, A. D. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01542-0 · Cited by 75
The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery
Blum, K., Thompson, B., Demotrovics, Z., Femino, J., Giordano, J., Oscar-Berman, M., Teitelbaum, S., Smith, D. E., Roy, A. K., Agan, G., et al. (2015) · Journal of Reward Deficiency Syndrome · doi:10.17756/jrds.2015-008 · Cited by 73
Venugopalan, V. V., Casey, K. F., O'Hara, C., O'Loughlin, J., Benkelfat, C., Fellows, L. K., & Leyton, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.135 · Cited by 70
Stimulant medications: how to minimize their reinforcing effects?
VOLKOW, N. D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.359 · Cited by 70
Cholinergic modulation of dopamine pathways through nicotinic acetylcholine receptors
de Kloet, S. F., Mansvelder, H. D., & De Vries, T. J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.014 · Cited by 69
Hellberg, S. N., Russell, T. I., & Robinson, M. J. F. (2019) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/s13415-018-00662-3 · Cited by 65
“This system is comprised of dopaminergic fibers that project from the ventral tegmental area in the midbrain, to limbic and cortical structures such as the nucleus accumbens, ventral pallidum, amygdala, and prefrontal cortex (Di Chiara & Imperato, 1988; T. E. Robinson & Berridge, 1993).”
Bailey, C. P., O'Callaghan, M. J., Croft, A. P., Manley, S. J., & Little, H. J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00146-0 · Cited by 66
Rorick-Kehn, L. M., Ciccocioppo, R., Wong, C. J., Witkin, J. M., Martinez-Grau, M. A., Stopponi, S., Adams, B. L., Katner, J. S., Perry, K. W., Toledo, M. A., et al. (2016) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13052 · Cited by 61
Cortico-striatal circuits: novel therapeutic targets for substance use disorders
Kravitz, A. V., Tomasi, D., LeBlanc, K. H., Baler, R., Volkow, N. D., Bonci, A., & Ferré, S. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.048 · Cited by 63
Age dependent nicotinic influences over dopamine neuron synaptic plasticity
Placzek, A. N., Zhang, T. A., & Dani, J. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.014 · Cited by 61
Nylander, I., Vlaskovska, M., & Terenius, L. (1995) · Psychopharmacology · doi:10.1007/bf02245939 · Cited by 61
Trim, R. S., Meehan, B. T., King, K. M., & Chassin, L. (2007) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.21.1.97 · Cited by 62
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
Jordi, E., Heiman, M., Marion-Poll, L., Guermonprez, P., Cheng, S. K., Nairn, A. C., Greengard, P., & Girault, J.-A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307116110 · Cited by 57
Persistent effects of obesity: A neuroplasticity hypothesis
Matikainen‐Ankney, B. A., & Kravitz, A. V. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13665 · Cited by 56
Ferger, B., Kropf, W., & Kuschinsky, K. (1994) · Psychopharmacology · doi:10.1007/bf02244852 · Cited by 55
Alcohol reinforcement and neuropharmacological therapeutics
LEWIS, M. J. (1996) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008214 · Cited by 54
Functions of the dopaminergic innervation of the nucleus accumbens.
Gray, J. A., Kumari, V., Lawrence, N., & Young, A. M. J. (1999) · Psychobiology · doi:10.3758/bf03332116 · Cited by 52
Lack of effect of acute dopamine precursor depletion in nicotine-dependent smokers
Casey, K. F., Benkelfat, C., Young, S. N., & Leyton, M. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.02.002 · Cited by 54
Brielmaier, J., McDonald, C. G., & Smith, R. F. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2378-1 · Cited by 54
Yacubian, J., & Büchel, C. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.015 · Cited by 53
From Disordered Eating to Addiction: The “Food Drug” in Bulimia Nervosa
Umberg, E. N., Shader, R. I., Hsu, L. K. G., & Greenblatt, D. J. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318252464f · Cited by 52
Straley, M. E., Van Oeffelen, W., Theze, S., Sullivan, A. M., O’Mahony, S. M., Cryan, J. F., & O’Keeffe, G. W. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.06.002 · Cited by 52
Robinson, J. E., Coughlin, G. M., Hori, A. M., Cho, J. R., Mackey, E. D., Turan, Z., Patriarchi, T., Tian, L., & Gradinaru, V. (2019) · eLife · doi:10.7554/elife.48983 · Cited by 44
Relationship between Substance Use and Body Mass Index in Young Males
Blüml, V., Kapusta, N., Vyssoki, B., Kogoj, D., Walter, H., & Lesch, O. M. (2012) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00192.x · Cited by 51
Rebec, G. V. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03614.x · Cited by 51
Schenk, S., & Highgate, Q. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15348 · Cited by 48
Cocaine addiction as a homeostatic reinforcement learning disorder.
Keramati, M., Durand, A., Girardeau, P., Gutkin, B., & Ahmed, S. H. (2017) · Psychological Review · doi:10.1037/rev0000046 · Cited by 44
Chiappini, S., & Schifano, F. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000814 · Cited by 44
A concurrent excitation and inhibition of dopaminergic subpopulations in response to nicotine
Eddine, R., Valverde, S., Tolu, S., Dautan, D., Hay, A., Morel, C., Cui, Y., Lambolez, B., Venance, L., Marti, F., et al. (2015) · Scientific Reports · doi:10.1038/srep08184 · Cited by 42
Modulation of cellular activity and synaptic transmission in the ventral tegmental area
Mathon, D. S., Kamal, A., Smidt, M. P., & Ramakers, G. M. J. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.097 · Cited by 41
Solecki, W., Ziolkowska, B., Krowka, T., Gieryk, A., Filip, M., & Przewlocki, R. (2009) · Brain Research · doi:10.1016/j.brainres.2008.12.002 · Cited by 39
Pedersen, K., Simonsen, M., Østergaard, S. D., Lajord Munk, O., Rosa-Neto, P., Olsen, A. K., Jensen, S. B., Møller, A., & Cumming, P. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.11.038 · Cited by 37
Deehan, G. A., Hauser, S. R., Wilden, J. A., Truitt, W. A., & Rodd, Z. A. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00104 · Cited by 38
Pharmacological Manipulation of Kv7 Channels as a New Therapeutic Tool for Multiple Brain Disorders
Vigil, F. A., Carver, C. M., & Shapiro, M. S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00688 · Cited by 36
Strickland, J. C., Gipson, C. D., & Dunn, K. E. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.835816 · Cited by 31
Imaging resilience and recovery in alcohol dependence
Charlet, K., Rosenthal, A., Lohoff, F. W., Heinz, A., & Beck, A. (2018) · Addiction · doi:10.1111/add.14259 · Cited by 29
Neurobiology and principles of addiction and tolerance
Turton, S., & Lingford-Hughes, A. (2016) · Medicine · doi:10.1016/j.mpmed.2016.09.007 · Cited by 24
Visanji, N. P., Mitchell, S. N., O'Neill, M. J., & Duty, S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.013 · Cited by 25
What the alcohol doctor ordered from the neuroscientist
Heilig, M., & Leggio, L. (2016) · Progress in Brain Research · doi:10.1016/bs.pbr.2015.07.023 · Cited by 25
Didone, V., Masson, S., Quoilin, C., Seutin, V., & Quertemont, E. (2016) · Addiction Biology · doi:10.1111/adb.12216 · Cited by 25
Dorsolateral caudate nucleus differentiates cocaine from natural reward-associated contextual cues
Liu, H.-S., Chefer, S., Lu, H., Guillem, K., Rea, W., Kurup, P., Yang, Y., Peoples, L., & Stein, E. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207531110 · Cited by 23
Dong, Y., Zhang, T., Li, W., Doyon, W., & Dani, J. A. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9231-6 · Cited by 23
The influence of postweaning housing conditions on drug-induced conditioned taste aversion
Smith, J. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00370-5 · Cited by 21
Claytor, R., Lile, J. A., & Nader, M. A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.03.007 · Cited by 19
Lee, J., Parish, C. L., Tomas, D., & Horne, M. K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.055 · Cited by 19
Udo de Haes, J. I., Kortekaas, R., Van Waarde, A., Maguire, R. P., Pruim, J., & den Boer, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0193-2 · Cited by 18
King, N., Floren, S., Kharas, N., Thomas, M., & Dafny, N. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172737 · Cited by 13
The role of ghrelin/GHS-R1A signaling in nonalcohol drug addictions
Sustkova-Fiserova, M., Charalambous, C., Khryakova, A., Certilina, A., Lapka, M., & Šlamberová, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020761 · Cited by 12
Vrettou, M., Thalhammer, S. B., Svensson, A.-L., Dumas, S., Nilsson, K. W., Wallén-Mackenzie, Å., Fredriksson, R., Nylander, I., & Comasco, E. (2023) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2023.100180 · Cited by 4
Volkow, N. D., Wang, G.-J., Begleiter, H., Porjesz, B., Fowler, J. S., Telang, F., Wong, C., Ma, Y., Logan, J., Goldstein, R., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.9.999 · Cited by 2
Metadata
- Authors
- Di Chiara, G., & Imperato, A.
- Affiliations
- Institute of Experimental Pharmacology and Toxicology, University of Cagliari, Italy.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1988-07
- Volume
- 85
- Issue
- 14
- Pages
- 5274-5278
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC281732
- OpenAlex
- W2165398609
- Cited by
- 4,733
- References
- 27
- Citations by year
- 2026: 62 · 2025: 104 · 2024: 78 · 2023: 112 · 2022: 141 · 2021: 133 · 2020: 160 · 2019: 155 · 2018: 162 · 2017: 141 · 2016: 183 · 2015: 173 · 2014: 194 · 2013: 193 · 2012: 163
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- drug abuse, extracellular dopamine, mesolimbic system, nucleus accumbens septi, dopamine release, hypermotility, hypomotility, kappa opioid receptor agonists, U50,488, tifluadom, bremazocine, haloperidol, imipramine, atropine, diphenhydramine, opiates, ethanol, nicotine, amphetamine, cocaine, limbic system
- MeSH terms
- Ethanol, Amphetamine, Animals, Caudate Nucleus, Cocaine, Dopamine, Homovanillic Acid, Kinetics, Male, Narcotics, Nicotine, Nucleus Accumbens, Rats, Inbred Strains, Receptors, Opioid, Septal Nuclei, Illicit Drugs, Synapses, Antipsychotic Agents, 3,4-Dihydroxyphenylacetic Acid, Receptors, Opioid, mu, Receptors, Opioid, kappa, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
